Is there a role for melatonin in the treatment of neoplastic cachexia?
- 1 July 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (8), 1340-1343
- https://doi.org/10.1016/0959-8049(96)00136-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Lower Survival in Metastatic Cancer Patients with Reduced Interleukin-2 Blood ConcentrationsOncology, 1991
- Endocrine and immune effects of melatonin therapy in metastatic cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1989
- Pineal Melatonin, Its Fundamental Immunoregulatory Role in Aging and CancerAnnals of the New York Academy of Sciences, 1988
- EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCERThe Lancet, 1987
- Melatonin: A Rediscovered Antitumor Hormone? Its Relation to Surface Receptors; Sex Steroid Metabolism, Immunologic Response, and Chronobiologic Factors in Tumor Growth and TherapyCancer Investigation, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- A clinical study of the pineal gland activity in oncologic patientsCancer, 1986
- HOW TUMORS AFFECT HOST METABOLISM*Annals of the New York Academy of Sciences, 1974
- THE ANOREXIA‐CACHEXIA SYNDROME: A NEW HYPOTHESISAnnals of the New York Academy of Sciences, 1974